Treatment outcome of multidrug-resistant tuberculosis in Japan – the first cross-sectional study of Japan tuberculosis surveillance data

BACKGROUND: Multidrug resistant-tuberculosis (MDR-TB) is a major global health concern. Its treatment requires toxic medications, is longer and costlier than drug-susceptible TB, and often results in productivity losses and poor outcomes. In Japan, a TB middle-burden country, reports on treatment ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawatsu, Lisa, Uchimura, Kazuhiro, Izumi, Kiyohiko, Ohkado, Akihiro, Yoshiyama, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119256/
https://www.ncbi.nlm.nih.gov/pubmed/30170549
http://dx.doi.org/10.1186/s12879-018-3353-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119256/
https://www.ncbi.nlm.nih.gov/pubmed/30170549
http://dx.doi.org/10.1186/s12879-018-3353-9

Ejemplares similares